Related Experiment Video
Updated: Mar 16, 2026

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
Nodular lymphocyte-predominant Hodgkin lymphoma
Kerry J Savage1, Anja Mottok2, Michelle Fanale3
1Department of Medical Oncology, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare cancer with a favorable prognosis despite relapses. This review covers its pathology, outcomes, and treatment, noting risks of secondary non-Hodgkin lymphoma.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare Hodgkin lymphoma subtype.
- Characterized by unique lymphocyte predominant (LP) cells (CD20(+), CD15(-), CD30(-)) within a nodular B-cell pattern.
- NLPHL has a favorable prognosis but carries a risk of secondary aggressive non-Hodgkin lymphoma (NHL), particularly with splenic involvement.
Purpose of the Study:
- To review the existing literature on Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).
- To describe pathological subtypes, patient outcomes, and current treatment approaches for NLPHL.
- To address the uncertainty in optimal management strategies due to the disease's rarity.
Main Methods:
- Literature review of pathological subtypes, outcomes, and treatment for NLPHL.
- Analysis of clinical and pathological features differentiating NLPHL from classical Hodgkin lymphoma (CHL).
- Examination of risk factors for secondary aggressive non-Hodgkin lymphoma (NHL).
Main Results:
- NLPHL is defined by specific LP cell markers (CD20+, CD15-, CD30-) in a nodular pattern.
- Despite frequent relapses, NLPHL generally has a very favorable prognosis.
- Splenic involvement at presentation increases the risk of secondary aggressive non-Hodgkin lymphoma (NHL).
Conclusions:
- Optimal management for NLPHL remains debated due to its rarity.
- Treatment paradigms may differ from classical Hodgkin lymphoma (CHL).
- Further research is needed to clarify the best treatment strategies for NLPHL.
Related Concept Videos
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Detailed Structure and Function of Lymph Nodes
From a histological perspective, lymph nodes can be split into two main areas: the superficial cortex and the deep medulla. The outer cortex is populated by dendritic cells, macrophages, and B lymphocytes, which are densely packed into follicles. When these B-lymphocytes are presented...
Cells of the Adaptive Immune Response
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

